Once-daily ceftriaxone therapy for serious bacterial infections in children

B. L. Congeni, T. Chonmaitree, T. A. Rakusan, Q. T. Box

    Research output: Contribution to journalArticle

    14 Scopus citations

    Abstract

    Ceftriaxone administered as a single daily dose of 50 mg/kg was evaluated in the treatment of 35 children with a variety of nonmeningitic bacterial infections. In two of the patients, the drug discontinued before the response to the drug could be evaluated. All of the remaining patients had a satisfactory response. In 22 of the patients, plasma was available for the determination of ceftriaxone levels 1 h after a dose and immediately before the next dose. All but one of these patients had trough ceftriaxone levels which exceeded the MIC of the infecting organism, although marginally so for Staphylococcus aureus. Ceftriaxone appears to be safe and effective in the treatment of a variety of bacterial pathogens in children when administered at a single daily dose of 50 mg/kg. This drug may be especially useful in those patients in whom outpatient antibiotic therapy is contemplated or in whom maintenance of intravenous access is difficult.

    Original languageEnglish (US)
    Pages (from-to)181-183
    Number of pages3
    JournalAntimicrobial Agents and Chemotherapy
    Volume27
    Issue number2
    DOIs
    StatePublished - Jan 1 1985

    ASJC Scopus subject areas

    • Pharmacology
    • Pharmacology (medical)
    • Infectious Diseases

    Fingerprint Dive into the research topics of 'Once-daily ceftriaxone therapy for serious bacterial infections in children'. Together they form a unique fingerprint.

  • Cite this